Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

December 01, 1996; 47 (6 Suppl 3) Articles

Pharmacology of selegiline

M. Gerlach, M.B.H. Youdim, P. Riederer
First published December 1, 1996, DOI: https://doi.org/10.1212/WNL.47.6_Suppl_3.137S
M. Gerlach
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M.B.H. Youdim
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. Riederer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Pharmacology of selegiline
M. Gerlach, M.B.H. Youdim, P. Riederer
Neurology Dec 1996, 47 (6 Suppl 3) 137S-145S; DOI: 10.1212/WNL.47.6_Suppl_3.137S

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
534

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Article Information

vol. 47 no. 6 Suppl 3 137S-145S
DOI: 
https://doi.org/10.1212/WNL.47.6_Suppl_3.137S

Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published December 1, 1996.

Copyright & Usage: 
Copyright 1996 by Advanstar Communications Inc.

Author Disclosures

    1. M. Gerlach, DPhil,
    2. M.B.H. Youdim, DPhil and
    3. P. Riederer, DPhil
  1. M. Gerlach, DPhil,
  2. M.B.H. Youdim, DPhil and
  3. P. Riederer, DPhil
  1. From the Division of Clinical Neurochemistry, University Hospital for Psychiatry, University of Wurzburg (Drs. Gerlach and Riederer); and the Department of Pharmacology, Faculty of Medicine, Technion, Haifa, Israel (Dr. Youdim).
  2. Supported by grants from the Bundesministerium fur Forschung und Technologie (01 KL 9013; 01 KL 9101-0) (Drs. Gerlach and Riederer); and Golding Parkinson Disease Research Fund Technion, Haifa (Dr. Youdim). The support of the European Community in Brussels (Biomed I) and Fogarty International Center for Advanced Studies, NIH Bethesda, is gratefully acknowledged.
  3. Address correspondence and reprint requests to Dr. Riederer, Psychiatrische Klinik und Poliklinik, Klinische Neurochemie, Fuchsleinstr. 15, D-97080 Wurzburg, Germany.
View Full Text

Article usage

Article usage: December 2007 to December 2022

AbstractFullPdfSource
Dec 2007200Highwire
Jan 2008200Highwire
Feb 2008200Highwire
Mar 2008700Highwire
Apr 2008500Highwire
May 2008400Highwire
Jun 2008211Highwire
Jul 20081201Highwire
Aug 2008601Highwire
Sep 2008500Highwire
Oct 20081300Highwire
Nov 20081500Highwire
Dec 2008721Highwire
Jan 2009500Highwire
Feb 2009900Highwire
Mar 20092100Highwire
Apr 20091000Highwire
May 2009500Highwire
Jun 20091500Highwire
Jul 2009500Highwire
Aug 20091200Highwire
Sep 2009702Highwire
Oct 20091000Highwire
Nov 20091800Highwire
Dec 2009800Highwire
Jan 20101000Highwire
Feb 2010600Highwire
Mar 20101000Highwire
Apr 20101501Highwire
May 20101000Highwire
Jun 20101500Highwire
Jul 20101000Highwire
Aug 20101700Highwire
Sep 2010801Highwire
Oct 20101501Highwire
Nov 2010610Highwire
Dec 20101301Highwire
Jan 20111400Highwire
Feb 20112601Highwire
Mar 20112602Highwire
Apr 20112730Highwire
May 20112700Highwire
Jun 20111722Highwire
Jul 20111311Highwire
Aug 20111500Highwire
Sep 20112330Highwire
Oct 20113101Highwire
Nov 20112721Highwire
Dec 20112100Highwire
Jan 20123600Highwire
Feb 20122400Highwire
Mar 20123201Highwire
Apr 20122800Highwire
May 20125801Highwire
Jun 20122101Highwire
Jul 20121300Highwire
Aug 20121401Highwire
Sep 20121603Highwire
Oct 20122302Highwire
Nov 20122502Highwire
Dec 20122100Highwire
Jan 2013600Highwire
Feb 20132300Highwire
Mar 20132300Highwire
Apr 20131811Highwire
May 20132110Highwire
Jun 2013801Highwire
Jul 20131300Highwire
Aug 2013600Highwire
Sep 20131300Highwire
Oct 20131011Highwire
Nov 20132900Highwire
Dec 20131000Highwire
Jan 20141800Highwire
Feb 2014900Highwire
Mar 20141802Highwire
Apr 2014700Highwire
May 20141215Highwire
Jun 2014700Highwire
Jul 20141301Highwire
Aug 20141100Highwire
Sep 20142701Highwire
Oct 20145332Highwire
Nov 20142214Highwire
Dec 20142401Highwire
Jan 20151310Highwire
Feb 2015900Highwire
Mar 20151000Highwire
Apr 20151600Highwire
May 20151400Highwire
Jun 2015800Highwire
Jul 20151000Highwire
Aug 2015500Highwire
Sep 2015700Highwire
Oct 20151833Highwire
Nov 20152100Highwire
Dec 20151100Highwire
Jan 20161723Highwire
Feb 20161100Highwire
Mar 20161400Highwire
Apr 20161700Highwire
May 2016600Highwire
Jun 20161600Highwire
Jul 2016600Highwire
Aug 2016500Highwire
Sep 20161700Highwire
Oct 20161101Highwire
Nov 2016700Highwire
Dec 20161500Highwire
Jan 2017800Highwire
Feb 20171500Highwire
Mar 20173200Highwire
Apr 20172310Highwire
May 20172600Highwire
Jun 20172600Highwire
Jul 20172212Highwire
Aug 20172201Highwire
Sep 20172610Highwire
Oct 20174312Highwire
Nov 20173900Highwire
Dec 20172900Highwire
Jan 20184702Highwire
Feb 20183101Highwire
Mar 20184902Highwire
Apr 20184101Highwire
May 20184903Highwire
Jun 20185002Highwire
Jul 20183100Highwire
Aug 20183400Highwire
Sep 20184003Highwire
Oct 201856610Highwire
Nov 20187002Highwire
Dec 20185805Highwire
Jan 20194404Highwire
Feb 20195202Highwire
Mar 20194403Highwire
Apr 20194204Highwire
May 20193703Highwire
Jun 20193414Highwire
Jul 20192601Highwire
Aug 20193401Highwire
Sep 20192310Highwire
Oct 20192623Highwire
Nov 20194409Highwire
Dec 20194804Highwire
Jan 20202400Highwire
Feb 20204014Highwire
Mar 20204515Highwire
Apr 20205503Highwire
May 20205713Highwire
Jun 20204205Highwire
Jul 20202205Highwire
Aug 20203005Highwire
Sep 202053111Highwire
Oct 20205113Highwire
Nov 20207312Highwire
Dec 20206104Highwire
Jan 20213401Highwire
Feb 20219726Highwire
Mar 20217134Highwire
Apr 20218633Highwire
May 20219002Highwire
Jun 20217004Highwire
Jul 20216602Highwire
Aug 20214508Highwire
Sep 20214409Highwire
Oct 202197010Highwire
Nov 202172019Highwire
Dec 20214406Highwire
Jan 20224519Highwire
Feb 20226018Highwire
Mar 2022108411Highwire
Apr 2022113226Highwire
May 202289133Highwire
Jun 202275127Highwire
Jul 202250219Highwire
Aug 202285028Highwire
Sep 202297135Highwire
Oct 202275235Highwire
Nov 2022145335Highwire
Dec 202299115Highwire

Cited By...

  • 106 Citations
  • Google Scholar

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Pharmacokinetic properties.
    • Irreversible inhibition of MAO-B.
    • Increase in activity of catecholaminergic neurons.
    • Neuroprotective, neurorescue, and neurorestorative action.
    • Possible mode of action in PD.
    • Conclusion.
    • REFERENCES
  • Figures & Data
  • Info & Disclosures
Advertisement

Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study

Dr. Robert Shapiro and Dr. Amynah Pradhan

► Watch

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published
Neurology: 100 (5)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise